Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Daniel M. Halperin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3113-930X; OpenAlex author ID A5012619170. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
2 (principal investigator on 2)
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2014: 1 paper, 1 trial · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 trial

Papers 2

  1. Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant Chemotherapy. Co-author DOI 10.1097/mpa.0000000000000914↗
  2. Resectable, borderline resectable, and locally advanced pancreatic cancer: what does it matter? Co-author DOI 10.1007/s11912-013-0366-9↗

Trials 2

  1. Chromogranin A as Blood Marker in Cancer Patients Principal investigator NCT03817866↗
  2. Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metasta… Principal investigator NCT02101918↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Gauri Rajani Varadhachary · 2 shared papers, 2014–2017 · strength 0.15
  2. Ignacio Ivan Wistuba · 1 shared paper, 2017 · strength 0.06
  3. Matthew H. G. Katz · 1 shared paper, 2017 · strength 0.06
  4. Jennifer Brooke Goldstein · 1 shared paper, 2017 · strength 0.06
  5. Huamin Wang · 1 shared paper, 2017 · strength 0.06
  6. Reza Nejati · 1 shared paper, 2017 · strength 0.06
  7. Hua Wang · 1 shared paper, 2017 · strength 0.06
  8. Robert A. Wolff · 1 shared paper, 2017 · strength 0.06
  9. Jorge M. Blando · 1 shared paper, 2017 · strength 0.06
  10. Jason B. Fleming · 1 shared paper, 2017 · strength 0.06
  11. Anirban Maitra · 1 shared paper, 2017 · strength 0.06
  12. Jeffrey E. Lee · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.